CG Oncology reported total assets of $1085.65M and total liabilities of $56.54M for the quarter ended Jun 2026, up 54.8% year over year. This balance sheet covers 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.09M | 0.62M | 1.47M | 2.29M | 3.13M | |||||||||
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash & EquivalentsCash & Equiv. | 8.27M | 77.47M | 25.16M | 43.41M | 257.07M | 41.47M | 14.62M | 45.15M | 32.49M | 33.70M | 19.64M | |||
| Receivables - NetNet Receivables | 0.09M | 0.15M | 0.18M | 0.14M | 0.34M | 0.56M | 0.52M | 0.69M | 1.27M | 0.42M | ||||
| Receivables | 0.09M | 0.15M | 0.18M | 0.14M | 0.34M | 0.56M | 0.52M | 0.69M | 1.27M | 0.42M | ||||
| Inventory | 1.50M | 1.56M | 1.49M | 1.00M | ||||||||||
| Prepaid Assets | 6.36M | 11.95M | 10.80M | 11.23M | 12.21M | 12.41M | 11.42M | 13.51M | 15.07M | 23.13M | 19.95M | |||
| Current Assets | 194.12M | 578.61M | 563.86M | 552.08M | 754.21M | 701.19M | 673.03M | 695.79M | 759.48M | 1,102.14M | 1,049.65M | |||
| Non-Current Assets | ||||||||||||||
| Property, Plant & Equipment (Net) | 0.07M | 0.08M | 0.08M | 0.06M | 0.27M | 0.26M | 0.25M | 15.33M | 15.60M | 15.07M | 14.71M | |||
| Goodwill | 12.80M | 10.30M | 10.30M | 10.30M | ||||||||||
| Intangibles | 1.70M | 0.57M | 0.56M | 0.55M | ||||||||||
| Goodwill & Intangibles | 14.51M | 10.87M | 10.86M | 10.84M | ||||||||||
| Other Non-Current Assets | 4.67M | 0.05M | 0.05M | 0.05M | 0.09M | 0.52M | 0.52M | 0.11M | 1.68M | 2.68M | 4.73M | |||
| Non-Current Assets | 5.18M | 0.50M | 0.47M | 0.39M | 0.59M | 26.99M | 28.41M | 34.12M | 32.12M | 33.12M | 36.01M | |||
| Assets | 199.30M | 579.11M | 564.33M | 552.47M | 754.80M | 728.18M | 701.45M | 729.91M | 791.59M | 1,135.26M | 1,085.65M | |||
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payables | 3.24M | 4.66M | 4.49M | 4.08M | 6.52M | 6.73M | 7.12M | 9.19M | 5.71M | 8.24M | 12.73M | |||
| Payables | 3.24M | 4.66M | 4.49M | 4.08M | 6.52M | 6.73M | 7.12M | 9.19M | 5.71M | 8.24M | 12.73M | |||
| Accumulated Expenses | 10.44M | 5.11M | 7.12M | 11.33M | 14.66M | 15.66M | 22.97M | 20.42M | 24.21M | 25.91M | 33.53M | |||
| Current Leases | 0.22M | 0.22M | 0.24M | 0.23M | 0.19M | 0.26M | 0.29M | 0.91M | 0.92M | 1.07M | 0.98M | |||
| Total Current Liabilities | 14.25M | 9.98M | 11.85M | 15.63M | 21.37M | 22.64M | 30.38M | 30.53M | 30.84M | 35.22M | 47.24M | |||
| Non-Current Liabilities | ||||||||||||||
| Non-Current Debt | 3.00M | 3.00M | 3.00M | 3.00M | ||||||||||
| Preferred Stock Liabilities | 120.00M | 120.00M | 120.00M | 120.00M | ||||||||||
| Operating Leases | 0.24M | 0.18M | 0.12M | 0.07M | 0.05M | 0.78M | 0.71M | 3.33M | 3.11M | 3.51M | 4.83M | |||
| Non-Current Deferred Tax Liability | 0.03M | |||||||||||||
| Other Non-Current Liabilities | 0.36M | 3.80M | 1.74M | 1.45M | 1.16M | |||||||||
| Total Non-Current Liabilities | 14.15M | 21.42M | 38.47M | 37.25M | 42.03M | 55.38M | ||||||||
| Total Liabilities | 86.12M | 97.39M | 107.58M | 14.51M | 10.17M | 11.97M | 15.70M | 21.42M | 23.42M | 31.09M | 42.27M | 38.99M | 43.48M | 56.54M |
| Shareholder's Equity | ||||||||||||||
| Total Debt | 3.00M | 3.00M | 3.00M | 3.00M | ||||||||||
| Common Equity | -86.12M | -97.39M | -107.58M | -123.10M | 568.94M | 552.36M | 536.77M | 733.38M | 704.76M | 670.36M | 687.64M | 752.60M | 1,091.78M | 1,029.12M |
| Liabilities and Shareholders Equity | 199.30M | 579.11M | 564.33M | 552.47M | 754.80M | 728.18M | 701.45M | 729.91M | 791.59M | 1,135.26M | 1,085.65M | |||
| Retained Earnings | -129.94M | 715.81M | 718.13M | 722.95M | 951.35M | 957.18M | 964.21M | 1,025.30M | 1,131.57M | 1,530.95M | 1,547.34M | |||
| Treasury Shares | 112.42M | 112.42M | 112.42M | 112.42M |